Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$8.19
+0.68%
Mkt Cap $1.45B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
Implied Upside
+7.8%
Consensus $8.82 vs current $8.19
NASDAQ·Healthcare·Biotechnology
$8.19
+0.68%
Mkt Cap $1.45B
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
+7.8%
Consensus $8.82 vs current $8.19